PharmaCompass

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

News

Bachem’s Sustainable TIDES Manufacturing

30 Oct 2024

// PRESS RELEASE

Inside Manufacturing at Bachem – A Day with Ronja Otter

13 Jan 2025

// PRESS RELEASE

How to Choose the Right CDMO Partner: Key Factors to Consider

20 Nov 2024

// PRESS RELEASE

Bachem’s Sustainable TIDES Manufacturing

30 Oct 2024

// PRESS RELEASE

Inside Manufacturing at Bachem – A Day with Ronja Otter

13 Jan 2025

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

In-cosmetics Global

Booth #5B149

Book a meeting

envelop Contact Supplier

CATEGORY PAGE

Bachem Ag

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2025, Corporate Presentation, Scaling Up: Major Investments in Peptide Production 2025, The Online Peptide Guide 2025, Oligonucleotide Generics 2025, Oligonucleotide Therapeutics 2025, SwissMedic GMP 2024, Goserelin Leuprorelin Triptorelin 2025, Pioneering Sustainable, Large-Scale Tides Manufacturing, Maintaining a Resilient Tides Supply Chain Under VUCA Conditions, Leading the Octreotide Scale-up, Scientific Expertise to Spring 2024 Conferences, Commerical Peptide NCE, Quality Grade Building Blocks, Innovations for Tides 2024, GMP Certificate 2023, Gorerelin Leuprorelin Triptorelin 2024, Commercial Peptide NCE 2024, Molecular Hiving™ Technology, Semaglutide 2024, Lanreotide, Back to Stirred Vessels & On to Metric Tons of Oligonucleotides, Increasing Sustainability in Large Scale Peptide API Purification, Solid Phase Peptide Synthesis 2023, Purification- A Bottleneck for Oligonucleotide API Manufacturing

Product List 2025
Corporate Presentation
Scaling Up: Major Investments in Peptide Production 2025
The Online Peptide Guide 2025
Oligonucleotide Generics 2025
Oligonucleotide Therapeutics 2025
SwissMedic GMP 2024
Goserelin Leuprorelin Triptorelin 2025
Pioneering Sustainable, Large-Scale Tides Manufacturing
Maintaining a Resilient Tides Supply Chain Under VUCA Conditions
Leading the Octreotide Scale-up
Scientific Expertise to Spring 2024 Conferences
Commerical Peptide NCE
Quality Grade Building Blocks
Innovations for Tides 2024
GMP Certificate 2023
Gorerelin Leuprorelin Triptorelin 2024
Commercial Peptide NCE 2024
Molecular Hiving™ Technology
Semaglutide 2024
Lanreotide
Back to Stirred Vessels & On to Metric Tons of Oligonucleotides
Increasing Sustainability in Large Scale Peptide API Purification
Solid Phase Peptide Synthesis 2023
Purification- A Bottleneck for Oligonucleotide API Manufacturing

VIDEO(s)

Acylated Peptide Synthesis- An Analysis of Cost & Capacity, Assess and Reduce Nitrosamine Contamination Risks in Peptide APIs, Avoiding Epimerization in Peptide Synthesis, Development for Novel Peptides: Column Screening to GMP Releases, Going Large-scale with Manufacturing of Oligonucleotides, Large-scale TIDES purification with MCSGP under GMP, Learn About Methods for Making Long and Complex Peptides, Mitigating Supply Chain Risks in an Age of Disruption, More Than White Powder and Reports, Navigating Regulatory Affairs Challenges for Successful Drugs, Peptide Aggregation – A Complex Topic, Regulatory Perspective- Expectations for Peptide Therapeutics, Scalable Oligonucleotide Manufacture With Stirred-bed Technology, Tag-assisted One-pot Liquid-phase Oligonucleotide Synthesis, Expert Round – Upscaling TIDES Manufacturing 2024, New Trends in Oligotherapeutics, 2nd Generation Process for the Manufacturing of Liraglutide, Innovation for Peptide & Oligonucleotide Manufacturing, Peptide-based In Vitro Diagnostics, Generic APIs-Liraglutide & Other GLP-1 Analogues, Oligonucleotide Facility Virtual Tour, Semaglutide, Leading by Experience in Generic API, Customer Testimonial, Continuous Chromatography of Peptides, Expanding into Oligos - Interview, Thiazine Formation: Elucidation of Thiol-Maleimide Side-Reaction, Oligonucleotides - Innovation that Transforms Lives, Interview with Torsten Wohr, The Perfect Ingredients for a Better World, Sherpany and Futurae

Acylated Peptide Synthesis- An Analysis of Cost & Capacity
Assess and Reduce Nitrosamine Contamination Risks in Peptide APIs
Avoiding Epimerization in Peptide Synthesis
Development for Novel Peptides: Column Screening to GMP Releases
Going Large-scale with Manufacturing of Oligonucleotides
Large-scale TIDES purification with MCSGP under GMP
Learn About Methods for Making Long and Complex Peptides
Mitigating Supply Chain Risks in an Age of Disruption
More Than White Powder and Reports
Navigating Regulatory Affairs Challenges for Successful Drugs
Peptide Aggregation – A Complex Topic
Regulatory Perspective- Expectations for Peptide Therapeutics
Scalable Oligonucleotide Manufacture With Stirred-bed Technology
Tag-assisted One-pot Liquid-phase Oligonucleotide Synthesis
Expert Round – Upscaling TIDES Manufacturing 2024
New Trends in Oligotherapeutics
2nd Generation Process for the Manufacturing of Liraglutide
Innovation for Peptide & Oligonucleotide Manufacturing
Peptide-based In Vitro Diagnostics
Generic APIs-Liraglutide & Other GLP-1 Analogues
Oligonucleotide Facility Virtual Tour
Semaglutide
Leading by Experience in Generic API
Customer Testimonial
Continuous Chromatography of Peptides
Expanding into Oligos - Interview
Thiazine Formation: Elucidation of Thiol-Maleimide Side-Reaction
Oligonucleotides - Innovation that Transforms Lives
Interview with Torsten Wohr
The Perfect Ingredients for a Better World
Sherpany and Futurae

DIGITAL CONTENT

56 Corporate Content #SupplierSpotlight, 3 Data Compilation #PharmaFlow, 123 News #PharmaBuzz

56 Corporate Content #SupplierSpotlight
3 Data Compilation #PharmaFlow
123 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

69 All APIs, 32 USDMF, 12 CEP/COS, 11 JDMF, 10 KDMF, 47 NDC API, 3 VMF, 23 Listed APIs

69 All APIs
32 USDMF
12 CEP/COS
11 JDMF
10 KDMF
47 NDC API
3 VMF
23 Listed APIs

KEY PRODUCTS

Atosiban, Bivalirudin, Glucagon, Glucagon Hydrochloride, Goserelin Acetate, Lanreotide Acetate, Leuprolide Acetate, Leuprolide Mesylate, Octreotide Acetate, Propofol, Semaglutide, Teriparatide, Teriparatide Acetate, Triptorelin Acetate, Triptorelin Pamoate

Atosiban
Bivalirudin
Glucagon
Glucagon Hydrochloride
Goserelin Acetate
Lanreotide Acetate
Leuprolide Acetate
Leuprolide Mesylate
Octreotide Acetate
Propofol
Semaglutide
Teriparatide
Teriparatide Acetate
Triptorelin Acetate
Triptorelin Pamoate

SERVICES

Analytical, API Manufacturing, API & Drug Product Development

Analytical
- 1 Analytical Method Development
API Manufacturing
API & Drug Product Development
- 3 API Development

KEY SERVICES

Custom Peptide Synthesis, CMO for Peptide & Oligonucleotide APIs

Custom Peptide Synthesis
CMO for Peptide & Oligonucleotide APIs

INSPECTIONS & REGISTRATIONS

33 FDA, 3 EDQM, 5 GDUFA, 9 Others

33 FDA
3 EDQM
5 GDUFA
9 Others

Active Filter(s):

PC100129

Privacy policy
Terms and conditions
Disclaimers
Ask Us!

America: Bachem Signs Large Volume Contracts For Peptides - Bachem Ag

CATEGORY PAGE

Bachem Ag

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

56 Corporate Content #SupplierSpotlight

3 Data Compilation #PharmaFlow

123 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

KEY PRODUCTS

SERVICES

Analytical

API Manufacturing

API & Drug Product Development

KEY SERVICES

INSPECTIONS & REGISTRATIONS